1. "Meeting abstract"
  2. "American Society of Clinical Oncology"
Formats
  1. Meeting Abstract (5703)
Groups
  1. Department of Medicine (4241)
  2. Solid Tumor Oncology Division (3715)
  3. Genitourinary Oncology Service (1266)
  4. Survivorship Research (1221)
  5. Surgery (1007)
  6. Epidemiology and Biostatistics (967)

More Groups

People
  1. Robert Motzer (321)
  2. Howard Scher (251)
  3. Eileen O'Reilly (212)
  4. Michael Morris (183)
  5. Leonard Saltz (172)
  6. Dean Bajorin (171)

More People

Years
  1. 2023 (451)
  2. 2022 (448)
  3. 2021 (400)
  4. 2020 (419)
  5. 2019 (398)
  6. 2018 (475)

More Years

Publications
  1. Journal of Clinical Oncology (5703)
Publishers
  1. American Society of Clinical Oncology (5703)

Results (5703)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRAS(G12C) mutation
    Meeting Abstract

    Pant, S.; Yaeger, R.; Spira, A. I.; Pelster, M.; Sabari, J. K.; Hafez, N.; Barve, M. A.; Velastegui, K.; Yan, X. H.; Der-Torossian, H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • EDGE-Gastric Arm A1: Phase 2 study of domvanalimab, zimberelimab, and FOLFOX in first-line (1L) advanced gastroesophageal cancer
    Meeting Abstract

    Janjigian, Y. Y.; Oh, D. Y.; Pelster, M.; Wainberg, Z. A.; Sison, E. A. R.; Scott, J. R.; Ronayne, J.; Wishengrad, D.; Rhee, J.; Nuyten, D. S. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy in survivors of cancer
    Meeting Abstract

    Lopez-Nieves, I.; Chiang, C.; Han, K.; Piulson, L.; Seluzicki, C.; Weitzman, M.; Zhang, Y. L.; Zhi, I.; Bao, T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment
    Meeting Abstract

    Saint, K.; Han, K.; Piulson, L.; Seluzicki, C.; Zhi, I.; Bao, T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Empathic communication skills training: Randomized controlled trial to reduce lung cancer stigma in lung cancer care
    Meeting Abstract

    Ostroff, J. S.; King, J. C.; Ciupek, A.; Nichols, B.; Malling, C.; Rosenthal, L.; Banerjee, S. C.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • SARC041: A phase 3 randomized double-blind study of abemaciclib versus placebo in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Ballman, K. V.; Weiss, M. C.; Attia, S.; Wagner, M. J.; Pollack, S.; Choy, E.; Wagner, A. J.; Wilky, B. A.; Davis, L. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 1 dose-expansion study of oral TP-1287, a cyclin-dependent kinase 9 (CDK9) inhibitor, in patients with Ewing sarcoma (EWS)
    Meeting Abstract

    Cote, G. M.; Wagner, A. J.; Charlson, J. A.; Hu, J. S.; Dickson, M. A.; D'Amato, G. Z.; Kabir, S.; Xu, B.; Lebedinsky, C.; von Mehren, M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • NOTOS: A pivotal study of navtemadlin, a first-in-class mouse double minute 2 inhibitor (MDM2i), in patients (pts) with TP53 wild-type (TP53(WT)) Merkel cell carcinoma (MCC) for whom anti PD-1/L1 therapy has failed
    Meeting Abstract

    Wong, M. K. K.; Burgess, M. A.; Chandra, S.; Fecher, L. A.; Gaudy-Marqueste, C.; Silk, A. W.; Hanna, G. J.; Lebbe, C.; Quéreux, G.; Rabinowits, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy
    Meeting Abstract

    Riedel, R. F.; Chawla, S. P.; Druta, M.; Jones, R. L.s; Schuetze, S.; Lam, J.; Zhuang, D.; Freddo, J. L.; Adams, B. J.; Theuer, C. P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save